Some results have been hidden because they may be inaccessible to you.Show inaccessible results
FDA-Approved VYZULTA® | Learn About Treatment Access
Sponsored(Latanoprostene Bunod Ophthalmic Solution), 0.024%. Help Patients Get Access To Treatment. ECPs: Your Eligible Commercially Insured Patients May Pay As Little As A $25 Copay.Mechanism of Action · Savings & Resources · Prescribing Information · Efficacy & Safety
Patient Site: VYZULTA® | FDA-Approved Treatment
Sponsored(Latanoprostene Bunod Ophthalmic Solution), 0.024%. Official Patient Website. Savings Offer Available. Visit Site To Learn More About VYZULTA Savings And Copay Info.About VYZULTA · Prescribing Information · Offers And Information · Savings Offer Available
Types: Download Resources, Savings & Support, Sign Up For Updates, How VYZULTA Works